-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Heterozygous Germline TET2 Loss Function Variants Predispose to Development of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: New Scientific Discoveries
Friday, December 6, 2024, 4:06 PM-4:56 PM

Sean Harrop

Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Disclosures: No relevant conflicts of interest to declare.

See more of: New Scientific Discoveries
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>